Inventor · disambiguated record
Edwin Clark
Also filed as: CLARK EDWIN · CLARK EDWIN A
8 granted patents·11 pending applications·40 citations·filing 2000–2012
84Inventor score
Top patents by PatentIndex Score
19 records- 0185US7932031B2Methods for determining sensitivity to microtubule-stabilizing agents comprising ixabepilone by measuring the level of estrogen receptor 1BRISTOL MYERS SQUIBB CO·Filed 2007·Granted Apr 26, 2011·12 cites·2 claims
- 0280US8007995B2Moesin, caveolin 1 and yes associated protein 1 as predictive markers of response to dasatinib in breast cancersBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Aug 30, 2011·13 cites·15 claims
- 0375US7338758B2Compositions and methods for the identification, assessment, prevention and therapy of human cancersMAYO FOUNDATION·Filed 2002·Granted Mar 4, 2008·4 cites·4 claims
- 0469US8129114B2Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulatorsFORD SHIRIN K·Filed 2006·Granted Mar 6, 2012·5 cites·14 claims
- 0568US7871775B2Compositions and methods for the identification, assessment, prevention and therapy of human cancersMILLENNIUM PHARM INC·Filed 2007·Granted Jan 18, 2011·0 cites·4 claims
- 0663US7504222B2Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2002·Granted Mar 17, 2009·6 cites·15 claims
- 0755US2012141604A1Novel compositions and methods for the identification, assessment, prevention and therapy of human cancersCLARK EDWIN·Filed 2011·Application pending·0 cites
- 0853US2009136961A1Novel compositions and methods for identification, assessment, prevention, and therapy of ovarian cancerMILLENNIUM PHARM INC·Filed 2008·Application pending·0 cites
- 0953US2010009358A1Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2008·Application pending·0 cites
- 1050US2011166154A1Identification of predictive markers of response to dasatinib in human colon cancerBRISTOL MYERS SQUIBB CO·Filed 2009·Application pending·0 cites
- 1146US8080368B2Compositions and methods for the identification, assessment, prevention and therapy of human cancersCLARK EDWIN·Filed 2010·Granted Dec 20, 2011·0 cites·10 claims
- 1246US2006121511A1Biomarkers and methods for determining sensitivity to microtubule-stabilizing agentsLEE HYERIM·Filed 2005·Application pending·0 cites
- 1345US7470509B2Compositions and methods for the identification, assessment, prevention and therapy of ovarian cancerMILLENNIUM PHARM INC·Filed 2003·Granted Dec 30, 2008·0 cites·19 claims
- 1445US2011104664A1Biomarkers and methods for determining sensitivity to micortubule-stabilizing agentsBRISTOL MYERS SQUIBB CO·Filed 2007·Application pending·0 cites
- 1544US2012195889A1Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulatorsFORD SHIRIN K·Filed 2012·Application pending·0 cites
- 1641US2010120788A1Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in prostate cellsBRISTOL MYERS SQUIBB CO·Filed 2008·Application pending·0 cites
- 1740US2001044414A1Metastasis genes and uses thereofWHITEHEAD BIOMEDICAL INST·Filed 2000·Application pending·0 cites
- 1839US2002015956A1Compositions and methods for the identification, assessment, prevention, and therapy of human cancersFiled 2001·Application pending·0 cites
- 1938US2010190150A1Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Edwin Clark files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →